| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Matthew C. Kapusta | CEO Managing Director | 2026-07-02 | 21,082 | $19.39 | $408.78kBuy |
| Matthew C. Kapusta | CEO Managing Director | 2026-07-02 | 7,600 | $45.89 | $348.76kSell |
| Matthew C. Kapusta | CEO Managing Director | 2026-07-02 | 4,282 | $45.43 | $194.53kSell |
| Matthew C. Kapusta | CEO Managing Director | 2026-07-02 | 9,200 | $44.43 | $408.76kSell |
| Jack Kaye | Director | 2026-06-30 | 17,060 | $20.18 | $344.27kBuy |
| Walid Abisaab | Chief Medical Officer | 2026-06-30 | 10,000 | $46.46 | $464.60kSell |
| Walid Abisaab | Chief Medical Officer | 2026-06-30 | 20,000 | $46.40 | $928.00kSell |
| Jack Kaye | Director | 2026-06-30 | 4,107 | $37.00 | $151.96kBuy |
| Jack Kaye | Director | 2026-06-30 | 4,107 | $46.49 | $190.93kSell |
| Jack Kaye | Director | 2026-06-30 | 17,060 | $46.43 | $792.10kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Avoro Capital Advisors LLC | 9.45% | 5,959,595 | $240.65M | Institution |
| Aberdeen Group PLC | 8.41% | 5,306,386 | $214.27M | Institution |
| Bv Foruniqure | 6.94% | 4,376,883 | $176.74M | Insider |
| Jpmorgan Chase Co | 4.50% | 2,837,466 | $114.58M | Institution |
| Two Sigma Investments LP | 4.24% | 2,675,871 | $108.05M | Institution |
| Rtw Investments LP | 4.10% | 2,586,356 | $104.44M | Institution |
| State Street Corp | 3.58% | 2,260,512 | $91.28M | Institution |
| Orbimed Advisors LLC | 3.39% | 2,136,149 | $86.26M | Institution |
| Fmr LLC | 2.76% | 1,743,808 | $70.41M | Institution |
| Blackrock Inc | 2.75% | 1,733,458 | $70.00M | Institution |